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osting by EAbstract Objectives: To evaluate the use of Hemostatic Fibrin Glue in parotidectomy without the
use of surgical drains.
Study design: Prospective cohort study of 10 patients undergoing parotidectomy. Surgery as a one
day admission without the use of surgical drains was planned. The complication and duration of the
hospital stay were obtained.
Methods: Parotidectomy was undertaken by one surgeon. Prior to wound closure, the skin ﬂap and
wound bed were approximated using Tisseel tissue sealant. Data regarding the incidence of any
complication and the duration of the hospital stay were obtained. Patients were followed to assess
surgical outcome and document any complications. The mean follow-up period was 8 months
(range 4–12 months).
Results: There were no major surgical complications. Two patients had facial nerve weakness due
to adherence of the tumour in the facial nerve, in there was which complete recovery after few
months. All patients were discharged the next day. None of the patients felt that the discharge
had been premature.
Conclusions: Parotidectomy can be undertaken safely without the need for surgical drains, there-
fore, allowing the patients to leave the hospital on the ﬁrst postoperative day.
ª 2010 King Saud University. Production and hosting by Elsevier B.V. All rights reserved..com
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lsevier1. Introduction
Parotidectomy is the deﬁnitive diagnostic and management
procedure for most parotid masses (Folia, 2003; Das, 2004).
Owing to the rich vascular supply to the parotid area, as well
as the possibility of salivary leakage from incised parotid
tissue, traditional postoperative management for parotidec-
tomy patients in many institutions includes the use of a percu-
taneous drain.
Percutaneous drains have a wide spectrum of associated
complications, including infection, ﬁstula formation, discom-
fort, psychosocial impact, and failure secondary to plugging,
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tions, the persistence of a percutaneous drain is an indication
for a patient to remain admitted postoperatively (Steckler,
1991).
Initial testing of tissue sealant consisting of ﬁbrinogen and
thrombin was undertaken by Young and Medawar (1940).
During the past two decades, the idea of using ﬁbrin glue as
a biological adhesive has gained popularity in various surgical
procedures including microneural repairs (Kuderna et al.,
1979), otolaryngologic surgery (Staindl, 1979), craniofacial
surgery (Marchac and Renier, 1990), and aesthetic surgery
(Bruck, 1982; Ellis and Pelausa, 1988; Mandel, 1990; Marchac
and Sandor, 1994).
Fibrin glue aids hemostasis by mirroring the ﬁnal common
pathway of the coagulation cascade and facilitates the close
apposition of surfaces for healing. These biological effects
allow a rapid healing with decreased rate of postoperative
complications and improve the ﬁnal cosmetic results. With
new techniques comes the opportunity to consider alternative
postoperative management approaches with speciﬁc surgical
procedures.
The Tisseel components are sterilized through a dry heat
and vapour heat protocols, and all donors are screened for
communicable diseases. To date, there have been no reported
or suspected cases of Tisseel-mediated transmission of any
communicable diseases, including hepatitis B, hepatitis C,
human immunodeﬁciency virus (HIV), or Creutzfeldt–Jakob
disease (Joch, 2003).
Tisseel is a commercially available ﬁbrin glue product that
has been used previously to reduce or eliminate the need for a
percutaneous drain in facial cosmetic surgery (Staindl, 1979;
Bruck, 1982; Marchac and Sandor, 1994; Marchac et al.,
1987). It is composed of human-derived thrombin and ﬁbrino-
gen, as well as bovine-derived aprotinin, which function to
form a ﬁbrin mesh in vivo independently from the proximal
coagulation cascade of either the intrinsic or the extrinsic path-
way. This mesh binds host platelets to form a thrombus, which
is stable for approximately 10–14 days in humans.
In the case of parotid surgery, it is possible to consider
using tissue glues to replace the need for surgical drains.
Without surgical drains, the need for planned prolonged
admission (>1 day) for the monitoring of drainage,
associated nursing care and bed availability issues can be
reconsidered.
This prospective study evaluates the use of tissue glue in
drainless parotid surgery, which evaluates the duration of hos-
pital stay and postoperative complication rate in parotidec-
tomy patients with the use of Tisseel.Table 1 Patient demographic information.
Total number 10
Mean age 39.8
Male 6
Female 4
Tail 2
Superﬁcial 6
Deep 22. Materials and methods
A prospective and consecutive cohort of 10 patients underwent
parotidectomy with facial nerve preservation (without neck
dissection) between March 2009 and November 2009 at King
Abdulaziz University Hospital, Riydah. In this cohort, 2 pa-
tients underwent partial parotidectomy, 6 had a superﬁcial
parotidectomy and 2 had a total parotidectomy. The cohort
consisted of 6 males and 4 females with a median age of
39.8 years (range 16–57 years). Nine of these patients had a
presumed benign disease process based on clinical ﬁndings
and investigations, including ﬁne-needle aspiration cytologyand imaging (CT). The surgery was planned as a overnight
stay without the use of surgical drains.
2.1. Surgical protocol
A standard, modiﬁed Blair parotidectomy incision was used
for each patient. A superﬁcial musculoaponeurotic system
platysmal ﬂap was raised. The parotidectomy procedure was
performed in a standard fashion. Following excision of the le-
sion, meticulous hemostasis was obtained.
A slow-setting mixture of ﬁbrin tissue glue was prepared
according to the manufacturer’s instructions. The preparation
used contains 500 IU/mL of human thrombin. Two milliliters
of the ﬁbrin glue was applied to the wound bed. The glue was
delivered to the area by a spray device (Duploject spray set and
Tissomat spray device, Baxter Corp.).
The skin ﬂap was reapproximated to the wound bed, and
sustained pressure was applied for 5 min. The superﬁcial skin
was then closed using a running absorbable suture. No drain
was used. All patients were discharged ﬁrst day post surgery.
Patients were followed to assess the surgical outcome and
document any complications. Patients were initially reviewed
10 days after their surgery. Any complications were
documented, as well as their experiences regarding the surgery.
The mean follow-up period was 8 months (range 4–12 months).
2.2. Data collection
The incidence of postoperative complications such as hema-
toma, salivary ﬁstula, wound dehiscence, necrosis, and facial
nerve paralysis were noted for all patients. The length of hos-
pital stay was noted for all the patients.
2.3. Statistical analysis
Statistical analysis was performed using SPSS, version 15.0 for
Windows.
3. Results
Ten patients were enrolled in this study. The demographics of
study patients are outlined in Table 1. The cohort consisted of
6 males and 4 females with a median age of 39.8 years (range
16–57 years). The mean follow-up period was 8 months (range
4–12 months).
In this cohort, 2 patients underwent partial parotidectomy,
6 had a superﬁcial parotidectomy and 2 had a total parotidec-
tomy. The surgical technique of identifying the facial nerve
were either antegrade (50%) or retrograde (50%) technique
Table 2.
Table 2 Type and technique of surgery.
Partial parotidectomy 2
Superﬁcial parotidectomy 6
Total parotidectomy 2
Antegrade technique 5
Retrograde technique 5
Table 3 Histopathology type.
Pleomorphic adenoma 8
Lipoma 1
Sebacous Ca 1
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cess based on clinical ﬁndings and investigations, including
ﬁne-needle aspiration cytology and imaging Table 3.
There were no cases of seroma, hematoma, ﬂap necrosis,
salivary ﬁstula or prolonged facial weakness. However, there
were two patients who had facial nerve paresis post opera-
tively, in which the facial nerve function came back to normal
after few months. Of these two patients, one had partial parot-
idectomy and the marginal mandibular nerve was adherent to
the tumour, in which the dissection of the nerve to separate it
from the mass caused a mild weakness. In the other case, pa-
tient had a deep lobe tumour, in which the dissection of the
nerve of the deep lobe mass caused a mild weakness in the low-
er branches.
Absence of cosmetic sequelae (facial paralysis and ecchy-
mosis or edema) and infection at the time of removal of dress-
ings permitted all patients to return to a normal life within
5 days after surgery.
In this cohort, all patients were discharged the next day. All
patients expressed satisfaction with their surgery. No patients
felt that the discharge had been premature.
4. Discussion
Within the specialty of otolaryngology-head and neck surgery,
tissue glue has been used in several situations, including facial
plastic surgery (Anderson and Baker, 2003), thyroidectomy
(Matthews and Briant, 1991; Lachachi et al., 2000), nasal sep-
tal surgery (Daneshrad et al., 2003), tonsillectomy (Viaman
et al., 2003), and more complex head and neck surgery (Kang
et al., 1998; Wiseman et al., 2002; Yoshimura and Kondoh,
2002).
The goal of parotid surgery is the eradication of disease
with minimal morbidity thereby allowing the patient to return
rapidly to normal living. During the last decade, the use of
alternate incisions (Cohen, 1988; Ferreria et al., 1990), and ﬁll-
ing of volume deﬁcits with transfer of tissues such as sterno-
cleidomastoid muscle (Bugis et al., 1990), free fat grafts
(Nosan et al., 1991; Harda et al., 1993), or SMAS applications
(Rappaport and Allison, 1985), resulted in acceptable cosmetic
results, but did not show any signiﬁcant reduction in the imme-
diate postoperative morbidity. Postoperative wound bleeding,
hematoma, and salivary ﬁstula were commonplace after parot-
idectomy (Matory and Spiro, 1993; Wax and Tarshis, 1991).There are different concentrations of thrombin available for
use in Tisseel. The one used in this study is the fast-setting
thrombin 500 IU/mL concentration, which functions more as
a hemostatic agent and a glue. The thrombin 4 IU/mL concen-
tration takes 1–2 min to set and functions more as a sealant.
Although the thrombin 4 IU/mL concentration has been used
successfully in facial cosmetic surgery in the past, the thrombin
500 IU/mL concentration is used in this study because the in-
stant hemostatic and glue properties were more likely to be
effective in the parotidectomy wound bed. In addition, the
duploject syringe application method was used because it pro-
vides a more controlled and directed application of the Tisseel
than the available spray attachment.
The potential for use of tissue sealant in patients undergo-
ing parotid surgery has been reported in a French cohort of 34
patients (with a same-sized cohort not receiving ﬁbrin tissue
glue) by Depondt andcolleagues (1996). The patients in the ﬁ-
brin glue group initially received a surgical drain, a practice
that was abandoned during the study. The patients all stayed
in hospital at least one night, and all patients had pressure
dressings applied that were maintained until the ﬁfth postoper-
ative day. The authors suggested that there were signiﬁcantly
fewer complications in the cohort that received tissue glue
and in particular in those patients developing a major hema-
toma. The numbers in the statistical comparisons were small,
and the rate of major hematoma recorded in the non–tissue
glue group was high (15%) compared with no major hemato-
mas in the tissue glue cohort, so the statistical result must be
viewed with caution. In this study, there were no cases of
hematoma.
A more recent randomized, controlled study compared
drainage volumes and the incidence of seromas between a
group of patients that received Tisseel to the parotid bed
and a group that did not. Maharaj and colleagues (2006)
concluded that the use of tissue glue signiﬁcantly decreases
both the total drainage volume and the frequency of postop-
erative seroma. This study differs in that it challenges the
assumption that a surgical drain is required for parotidec-
tomy surgery.
Prompted by the beneﬁcial results reported with ﬁbrin glue
in face-lift procedures (Marchac et al., 1987), I used the tissue
adhesive for parotidectomy closures and noted a signiﬁcant
reduction in the rate of postoperative complications. There
was a decrease in the overall incidence of hematomas. Marchac
and Sandor(1994) believed that the ﬁbrin glue traps and limits
the spread of bleeding, producing minor instead of major
hematomas, allowing them to be treated by simple aspiration.
However, in this study there were no major nor minor
hematomas.
Contrary to the opinion of Ellis and Pelausa (Ellis and
Pelausa, 1988) that saliva may inactivate or degrade the ﬁbrin
glue. Depondt and colleagues (1996), salivary ﬁstulae were
noted in 2 of 34 patients treated with ﬁbrin glue, and these ﬁs-
tulae occurred typically at the exit of the drains. In my study
salivary ﬁstula was not noted in any of the patients treated.
Surprisingly, no ﬁstulae were noted since the omission of
drains from 1994 onwards. We believe that drains promote sal-
ivary ﬁstulae by allowing the secretions to drain externally. In
contrast, total omission of the drain permitted ﬁbrin glue to
completely seal the ﬂap to the deep tissues, leaving no pockets
and preventing the occurrence of salivary ﬁstulae (Depondt
et al., 1996).
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postoperative facial paralysis was always associated with a ma-
jor hematoma in the group of patients who had traditional
parotidectomy closure, whereas this complication was com-
pletely absent in the ﬁbrin glue-treated group. However, in
my study, the two postoperative facial nerve pareses were
due to the adherence of the tumour to the marginal mandibu-
lar nerve, in which the dissection of the nerve to separate it
from the mass caused a mild weakness in one case, and in
the other case, the patient had a deep lobe tumour, in which
the dissection the nerve of the deep lobe mass caused a mild
weakness in the lower branches. Therefore, I do not believe
that the hemostatic action of the ﬁbrin glue may reduce the
risk of facial nerve paralysis by decreasing the risk of hema-
toma formation.
Steckler (1991) ﬁrst reported the feasibility of performing
outpatient parotidectomy. Despite rigorous preoperative selec-
tion, 10 of his 54 patients were readmitted for the treatment of
complications. In my study, I used ﬁbrin glue for closures after
resection of benign and malignant parotid lesions and ob-
served a marked reduction in the complication rate. Parotidec-
tomy without drains permitted all patients to leave the hospital
on the ﬁrst postoperative day. No patient required readmission
for the treatment of a complication.
The trend over the past 30 years has been to perform more
surgery on a day surgery basis. Medical insurance providers
are keen to reduce costs and may have helped drive this trend
to increased day surgery through their reimbursement policies
of the costs related to hospital stays. This effect is likely to con-
tinue as operations that were once considered to need over-
night hospital admission had begun to be undertaken more
routinely as daycare procedures.
The current cost of Tisseel in Saudi Arabia is approxi-
mately $350/mL, bringing the cost for intervention per patient
to approximately $700. The decrease in the complication rate
demonstrated in this study justiﬁes this cost.
5. Conclusions
Hemostatic actions of ﬁbrin glue precluded the necessity of
usage of drains, also, it resulted in decrease in the volume of
postoperative wound drainage and the frequency of postoper-
ative hematoma and seroma. Parotidectomy can be under-
taken safely in a day surgery setting without the need for
surgical drains, therefore, allowing the patients to leave the
hospital on the ﬁrst postoperative day.
The future research will be doing the parotidectomy with-
out drains as day surgery, so the patient can be discharged
in the same day of the surgery, and this will solve the problem
of bed shortage in some of the hospitals.
That will lead to the reduction in cost of the day surgery
compared to hospital stay. Therefore, Medical insurance pro-
viders are keen to reduce costs and may have helped drive this
trend to increased day surgery through their reimbursement
policies of the costs related to hospital stays.
References
Anderson, K.W., Baker, S.R., 2003. Advances in facial rejuvenation
surgery. Curr. Opin. Otolaryngol. Head Neck Surg. 11, 256–260.
Bruck, H.G., 1982. Fibrin tissue adhesion and its use in rhytidectomy.
A pilot study. Aesthet. Plast. Surg. 6, 197–202.Bugis, S.P., Young, J., Archibald, S.D., 1990. Sternocleidomastoid ﬂap
following parotidectomy. Head Neck Surg. 12, 430–435.
Cohen, S., 1988. Personal experience with an alternate incision for
parotidectomy. J. Otolaryngol. 17, 382–384.
Daneshrad, P., Chin, G.Y., Rice, D.H., 2003. Fibrin glue prevents
complications of septal surgery: ﬁndings in a series of 100 patients.
Ear Nose Throat J. 82, 196–197.
Das, D.K., 2004. Role of ﬁne needle aspiration cytology in the
diagnosis of swellings in the salivary gland regions: a study of 712
cases. Med. Princ. Pract. 13, 95–106.
Depondt, J., Koka, V.N., Nasser, T., et al., 1996. Use of ﬁbrin glue in
parotidectomy closure. Laryngoscope 106, 784–787.
Ellis, D.A.F., Pelausa, E.O., 1988. Fibrin glue in facial plastic and
reconstructive surgery. J. Otolaryngol. 17, 74–77.
Ferreria, J.L., Maurino, N., Michael, E., et al., 1990. Surgery of the
parotid region: a new approach. J. Oral Maxillofac. Surg. 48, 803–
807.
Folia, M., 2003. Value of ﬁne-needle aspiration cytology and MRI in
parotid gland masses. Rev. Laryngol. Otol. Rhinol. (Bord.) 123,
153–157.
Harda, T., Inoue, T., Harashina, T., et al., 1993. Dermis-fat graft after
parotidectomy to prevent Frey’s syndrome and the concave
deformity. Ann. Plast. Surg. 31, 450–452.
Joch, C., 2003. The safety of ﬁbrin sealants. Cardiovasc. Surg. 11
(Suppl. 1), 23–28.
Kang, D.R., Leong, H., Foss, R., et al., 1998. Sutureless cartilage
graft laryngotracheal reconstruction using ﬁbrin sealant. Arch.
Otolaryngol. Head Neck Surg. 124, 665–670.
Kuderna, H., Redl, H., Dinges, H., 1979. The repair of several
peripheral nerves by means of a ﬁbrin seal. Clinical experience and
results. Eur. Surg. Res. 11 (Suppl. 2), 98–99.
Lachachi, F., Descottes, B., Durand-Fontanier, S., et al., 2000. The
value of ﬁbrin sealant in thyroid surgery without drainage. Int.
Surg. 85, 344–346.
Maharaj, M., Diamond, C., Williams, D., et al., 2006. Tisseel to
reduce post parotidectomy wound drainage: randomized, prospec-
tive, controlled trial. J. Otolaryngol. 35, 36–39.
Mandel, M.A., 1990. Closure of blepharoplasty incisions with autol-
ogous ﬁbrin glue. Arch. Ophthalmol. 108, 842–844.
Marchac, D., Renier, D., 1990. Fibrin glue in craniofacial surgery. J.
Craniofac. Surg. 1, 32–34.
Marchac, D., Sandor, G., 1994. Face lifts and sprayed ﬁbrin glue: an
outcome analysis of 200 patients. Br. J. Plast. Surg. 47, 306–309.
Marchac, D., Pugash, E., Gault, D., 1987. The use of sprayed ﬁbrin
glue for face lift procedures. Eur. J. Plast. Surg. 10, 139–143.
Matory, Y.L., Spiro, R.H., 1993. Wound bleeding after head and neck
surgery. J. Surg. Oncol. 53, 17–19.
Matthews, T.W., Briant, T.D., 1991. The use of ﬁbrin tissue glue in
thyroid surgery: resource utilization implications. J. Otolaryngol.
20, 276–278.
Nosan, D.K., Ochi, J.W., Davidson, T.M., 1991. Preservation of facial
contour during parotidectomy. Otolaryngol. Head Neck Surg. 104,
293–298.
Rappaport, I., Allison, G.R., 1985. Superﬁcial musculoaponeurotic
system amelioration of parotidectomy defects. Ann. Plast. Surg. 14,
315–323.
Reid, R.R., 2003. A minimalist approach to the care of the indwelling
closed suction drain: a prospective analysis of local wound
complications. Ann. Plast. Surg. 51, 575–578.
Staindl, O., 1979. Healing of wounds and scar formation under the
inﬂuence of a tissue adhesion system with ﬁbrinogen, thrombin,
and coagulation factor XIII. Arch. Otorhinolaryngol. 222, 241–
245.
Steckler, R.M., 1991. Outpatient parotidectomy. Am. J. Surg. 162,
303–305.
Viaman, M., Eviatar, E., Shlamkovich, N., Segal, S., 2003. Effect of
modern ﬁbrin glue on bleeding after tonsillectomy and adenoidec-
tomy. Ann. Otol. Rhinol. Laryngol. 112, 410–414.
Initial experience with hemostatic ﬁbrin glueas adjuvant during drainless parotidectomy 71Wax, M., Tarshis, L., 1991. Post-parotidectomy ﬁstula. J. Otolaryngol.
20, 10–13.
Wiseman, S., Hicks, W.J., Loree, T., et al., 2002. Fibrin glue-
reinforced closure of postlaryngectomy pharyngocutaneous ﬁstula.
Am. J. Otolaryngol. 23, 368–373.Yoshimura, Y., Kondoh, T., 2002. Treatment of chylous ﬁstula with
ﬁbrin glue and clavicular periosteal ﬂap. Br. J. Oral Maxillofac.
Surg. 40, 138–139.
Young, J.Z., Medawar, P.G., 1940. Fibrin suture for peripheral nerves;
measurement of rate of regeneration. Lancet 2 (6101), 126–128.
